Medication info

Tinasil Tablets (Terbinafine Hydrochloride)

Prescription medicationExpired
Ingredient · strength
Terbinafine Hydrochloride›Strength being verified
Manufacturer / importer
Dongkwang Pharmaceutical Co., Ltd.
Appearance
Round tablets, white to pale yellow
Packaging
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Expired

MFDS item code 200500168 · Approved 2005.01.19

This product's status changed to Expired on 2023.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis in children
Who uses it
Adults · Children
Adult dosage
Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris (jock itch): 2~4 weeks 2) Onychomycosis Treatment is usually continued for 6 weeks~3 months. In cases of infection of a fingernail or a relatively small toenail, or in younger patients, the treatment duration may be shortened to 3 months or less. A treatment duration of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL/minute.
Children's dosage
Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be given regularly and for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with its use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Ingredients

Manufacturer
Dongkwang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of onychomycosis, cutaneous fungal infections (such as tinea pedis and tinea corporis), and tinea capitis in children

  • Dermatophyte infections
  • tinea pedis
  • tinea corporis
  • tinea cruris
  • onychomycosis
  • tinea capitis
View approved original text

This medicine is used in adults to treat dermatophyte infections such as tinea pedis, tinea corporis, and tinea cruris caused by dermatophytes, as well as onychomycosis. It is also effective for the treatment of tinea capitis in children. In other words, it is used to treat various skin and nail fungal infections.

Dosage and Administration

Adult dosage

Administer terbinafine at a dose of 125 mg twice daily or 250 mg once daily. The duration of treatment according to the condition is as follows. 1) Dermatophytosis Tinea pedis (interdigital or plantar/moccasin type): 2~6 weeks Tinea corporis: 2∼4 weeks Tinea cruris (jock itch): 2~4 weeks 2) Onychomycosis Treatment is usually continued for 6 weeks~3 months. In cases of infection of a fingernail or a relatively small toenail, or in younger patients, the treatment duration may be shortened to 3 months or less. A treatment duration of 3 months is usually sufficient for toenail infections, but some patients may require 6 months or longer. Treatment may take longer in patients with slow nail growth. Reduce the daily dose by 1/2 in patients with creatinine clearance below 50 mL/minute.

Children's dosage

Administer to children aged 2 years and older. Administration is not recommended for children under 2 years of age because there is no experience with its use in this age group. Tinea capitis: 4 weeks Tinea capitis occurs mainly in children. To prevent recurrence of the infection, treatment should be given regularly and for the appropriate prescribed duration. Body weight less than 20 kg (under 5 years): Administer 62.5 mg per dose once daily. Because experience with its use is limited, the decision to administer should be based on consideration of the benefits and risks of treatment. Body weight 20~40 kg (5~12 years): Administer 125 mg per dose once daily. Body weight over 40 kg (over 12 years): Administer 250 mg per dose once daily.

Precautions

This medication is not recommended for patients with chronic liver disease or active liver disease. The liver health status must be checked before prescribing, and liver function tests should be performed regularly to closely monitor for liver damage. If symptoms of liver dysfunction arise, the use of this medication should be discontinued immediately and a doctor should be consulted. Furthermore, it should not be administered to patients with blood diseases, severe renal impairment, breastfeeding women, or children under the age of 2. This medication can cause serious skin reactions or allergic reactions; therefore, if any abnormal skin symptoms occur, the medication should be stopped immediately. Caution is also needed if symptoms such as muscle pain or joint pain appear, and if the symptoms are severe, medical consultation is necessary. This medication may interact with other drugs, so if there are other medications being taken, they must be disclosed to the healthcare provider. Women who are pregnant or may become pregnant should consider the use of this medication carefully, and if breastfeeding, it is recommended to discontinue breastfeeding. The dosage and administration should be carefully determined for the elderly or underweight children. In case of overdose, symptoms such as headache, nausea, and dizziness may appear, so in such cases, it is important to visit a medical facility immediately for appropriate treatment. This medication should be stored in a tightly closed container to prevent air or moisture from entering. Additionally, it should be stored at room temperature, ideally between 1°C and 30°C, and kept out of reach of children. Moreover, transferring the medication to another container could affect its quality and should be avoided.

Side effects

Persistent nausea, decreased appetite, fatigue, vomiting, right upper quadrant pain, jaundice, dark urine, loose stools, biliary system failure, hepatitis, cholestasis, jaundice, rash, skin itching, fever, nausea, vomiting, loss of appetite, lethargy, γ-GTP elevation, AST/ALT elevation, LDH elevation, ALP elevation, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, pharyngitis, fever, lymphadenopathy, purpura, subcutaneous hemorrhage, leukopenia, anemia, rash, itching, photosensitivity reaction, skin mucous membrane syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, erythema multiforme, toxic skin rash, exfoliative dermatitis, vesicular dermatitis, psoriasiform rash, exacerbation of psoriasis, hair loss, musculoskeletal reactions, arthralgia, myalgia, weakness, CPK elevation, rhabdomyolysis, hypotension, dyspnea, chest tightness, urticaria, erythema, facial edema, lymphangiectasia, abdominal distension, dyspepsia, mild abdominal pain, diarrhea, gastric discomfort, thirst, glossitis, depression, anxiety, headache, taste disturbance, dizziness, drowsiness, sensory abnormalities, sensory reduction, attention deficit, insomnia, BUN elevation, polyuria, visual impairment, tinnitus, anaphylactic reaction, angioedema, systemic lupus erythematosus, elevated total cholesterol, elevated triglycerides, lethargy, tongue discoloration, palpitations, edema, menstrual irregularities, paralysis, systemic disorders, fever, fatigue, weight loss, anaphylactic reaction, serum sickness-like reaction, blurred vision, vision impairment, hearing loss, auditory impairment, vasculitis, permanent loss of smell, anosmia, hyposmia, drug rash with eosinophilia and systemic symptoms, pancreatitis, rhabdomyolysis, influenza-like illness, increased blood creatine phosphokinase, headache, nausea, upper abdominal pain, dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture ingress. The best storage temperature is at room temperature, between 1°C and 30°C.

Appearance and packaging

Appearance

Round tablets, white to pale yellow

Package unit

30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.